nach oben

AIDS and Behavior

Erschienen in:

21.10.2019 | Original Paper

Effectiveness of an Intervention for Improving Treatment Adherence, Service Utilization and Viral Load Among HIV-Positive Adult Alcohol Users

verfasst von: Jennifer Attonito, Karina Villalba, Jessy G. Dévieux

Erschienen in: AIDS and Behavior | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

This study evaluates whether a group intervention that included cognitive remediation improved ART adherence, service utilization, and viral load among HIV-positive adults with a history of alcohol abuse. HIV-seropositive adults (n = 243), recruited from community-based organizations were randomized to the Holistic Health Recovery Program (HHRP-A) or a comparison condition. Both conditions included eight group sessions; outcomes (adherence, service utilization, and viral load) and processes (social support and stress) were measured. Data were collected at baseline, immediately post-intervention, 3 months, and 6 months follow-up. Participants were ≥ 18 and ≤ 60 (\({\bar{\text{X}}} = 4 5. 2\) years old), 71% male, and 79.6% black. Participants randomized to HHRP-A were more likely to report adequate ART adherence and to report an undetectable viral load at 6 months post-intervention. Participants in the HHRP-A condition showed significantly greater improvement in social support than the comparison group. Providing comprehensive health promotion interventions that incorporate cognitive remediation strategies, could improve health outcomes for HIV-positive substance users.

Günthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel. JAMA. 2016;16(2):191–210. https://doi.org/10.1001/jama.2016.8900.CrossRef

Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART). AIDS Behav. 2015;19(4):601–11. https://doi.org/10.1007/s10461-014-0927-4.CrossRefPubMedPubMedCentral

Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96. https://doi.org/10.1007/s10461-011-9942-x.CrossRefPubMed

Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14(6):1213–26. https://doi.org/10.1007/s10461-010-9684-1.CrossRefPubMedPubMedCentral

Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93. https://doi.org/10.1016/j.drugalcdep.2010.06.014.CrossRefPubMedPubMedCentral

Cunningham WE, Sohler NL, Tobias C, et al. Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the US population in care. Med Care. 2006;44(11):1038–47. https://doi.org/10.1097/01.mlr.0000242942.17968.69.CrossRefPubMed

Rothlind JC, Greenfield TM, Bruce AV, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11(1):70–83. https://doi.org/10.1017/S1355617705050095.CrossRefPubMedPubMedCentral

Bernardin F, Maheut-Bosser A, Paille F. Cognitive impairments in alcohol-dependent subjects. Front Psychiatry. 2014;5:78.CrossRefPubMedPubMedCentral

Galvan F, Bing E, Fleishman J, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol Drugs. 2002;63(2):179. https://doi.org/10.15288/jsa.2002.63.179.CrossRef

10.

Sacktor N, Skolasky RL, Seaberg E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016;86(4):334–40. https://doi.org/10.1212/WNL.0000000000002277.CrossRefPubMedPubMedCentral

11.

Bass JK, Bornemann TH, Burkey M, et al. A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come. PLoS Med. 2012;9(1):e1001159. https://doi.org/10.1371/journal.pmed.1001159.CrossRefPubMedPubMedCentral

12.

Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med. 2014;21(5):811–20. https://doi.org/10.1007/s12529-013-9353-7.CrossRefPubMedPubMedCentral

13.

Barai N, Monroe A, Lesko C, et al. The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV. AIDS Behav. 2017;21(7):1836–45. https://doi.org/10.1007/s10461-016-1580-x.CrossRefPubMedPubMedCentral

14.

Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71. https://doi.org/10.1093/cid/cit420.CrossRefPubMed

15.

Chang SJ, Choi S, Kim SA, Song M. Intervention strategies based on information-motivation-behavioral skills model for health behavior change: a systematic review. Asian Nurs Res. 2014;8(3):172–81. https://doi.org/10.1016/j.anr.2014.08.002.CrossRef

16.

Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203. https://doi.org/10.1007/s11904-008-0028-y.CrossRefPubMed

17.

Margolin A, Avants S, Warburton L, Hawkins K, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22(2):223–8. https://doi.org/10.1037/0278-6133.22.2.223.CrossRefPubMed

18.

Smith LR, Fisher JD, Cunningham CO, Amico KR. Understanding the behavioral determinants of retention in HIV care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDs. 2012;26(6):344–55. https://doi.org/10.1089/apc.2011.0388.CrossRefPubMedPubMedCentral

19.

Farinpour R, Martin EM, Seidenberg M, Pitrak DL, Pursell KJ, Mullane KM, Novak RM, Harrow M. Verbal working memory in HIV-seropositive drug users. J Int Neuropsychol Soc. 2000;6(5):548–55. https://doi.org/10.1017/S1355617700655042.CrossRefPubMed

20.

Cohen S, McKay G. Social support, stress and the buffering hypothesis: A theoretical analysis. In: Baum A, Taylor SE, Singer JE, editors. Handbook of Psychology and Health, vol. 4. New York: Springer; 1984. p. 253–67.

21.

Kalichman SC, Kalichman MO. HIV-related stress and life chaos mediate the association between poverty and medication adherence among people living with HIV/AIDS. J Clin Psychol Med Settings. 2016;23(4):420–30. https://doi.org/10.1007/s10880-016-9481-8.CrossRefPubMed

22.

DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207. https://doi.org/10.1037/0278-6133.23.2.207.CrossRefPubMed

23.

Babor TJ, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care. 2nd ed. Geneva: World Health Organization; 2001. https://apps.who.int/iris/handle/10665/67205.

24.

Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10–22. https://doi.org/10.1080/09540120412331305098.CrossRefPubMed

25.

McLellan AT, Alterman AI, Cacciola J, Metzger D, O’Brien CP. A new measure of substance abuse treatment: initial studies of the treatment services review. J Nerv Ment Dis. 1992;180(2):101–10. https://doi.org/10.1097/00005053-199202000-00007.CrossRefPubMed

26.

Mannheimer S, Friedland G, Matts J, Child C, Chesney M, Terry Beirn Community Programs for Clinical Research on AIDS. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for Human Immunodeficiency Virus—infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21. https://doi.org/10.1086/339074.CrossRefPubMed

27.

Sherbourne C, Stewart A. The MOS Social Support Survey. Soc Sci Med. 1991;32(6):705–14. https://doi.org/10.1016/0277-9536(91)90150-B.CrossRefPubMed

28.

Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. Consult Clin Psychol. 1978;46(5):932. https://doi.org/10.1037/0022-006X.46.5.932.CrossRef

29.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96. https://doi.org/10.2307/2136404.CrossRefPubMed

30.

Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004;26(2):67–78. https://doi.org/10.1016/S0740-5472(03)00159-4.CrossRefPubMed

31.

Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley; 2014.

32.

Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99. https://doi.org/10.1212/01.WNL.0000287431.88658.8b.CrossRefPubMed

33.

Malow RM, Dévieux JG, Stein JA, et al. Neurological function, information–motivation–behavioral skills factors, and risk behaviors among HIV-positive alcohol users. AIDS Behav. 2012;16(8):2297–308. https://doi.org/10.1007/s10461-012-0246-6.CrossRefPubMed

34.

Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ. Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence. Neurobehav HIV Med. 2012;4:113–21. https://doi.org/10.2147/NBHIV.S36549.CrossRefPubMedPubMedCentral

35.

Kahana SY, Rohan J, Allison S, Frazier TW, Drotar D. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. AIDS Behav. 2013;17(1):41–60. https://doi.org/10.1007/s10461-012-0159-4.CrossRefPubMed

36.

Kim TW, Kertesz SG, Horton NJ, Tibbetts N, Samet JH. Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. BMC Health Serv Res. 2006;6(1):19. https://doi.org/10.1186/1472-6963-6-19.CrossRefPubMedPubMedCentral

37.

Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18(4):306–12. https://doi.org/10.1016/j.drugpo.2007.03.001.CrossRefPubMedPubMedCentral

38.

O’Leary A. Social-cognitive theory mediators of behavior change in the National Institute of Mental Health Multisite HIV Prevention Trial. Health Psychol. 2001;20(5):369. https://doi.org/10.1037//0278-6133.20.5.369.CrossRef

39.

Lopez C, Antoni M, Penedo F, et al. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. J Psychosom Res. 2011;70(4):328–34. https://doi.org/10.1016/j.jpsychores.2010.11.010.CrossRefPubMedPubMedCentral

40.

Lutgendorf SK, Antoni MH, Ironson G, et al. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med. 1998;60(2):204–14. https://doi.org/10.1097/00006842-199803000-00017.CrossRefPubMed

41.

Lehavot K, Huh D, Walters KL, King KM, Andrasik MP, Simoni JM. Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care STDs. 2011;25(3):181–9. https://doi.org/10.1089/apc.2010.0314.CrossRefPubMedPubMedCentral

42.

Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45. https://doi.org/10.1007/s10461-006-9078-6.CrossRefPubMedPubMedCentral

43.

Horvath KJ, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care. 2014;26(2):142–51. https://doi.org/10.1080/09540121.2013.802283.CrossRefPubMed

Titel: Effectiveness of an Intervention for Improving Treatment Adherence, Service Utilization and Viral Load Among HIV-Positive Adult Alcohol Users
verfasst von: Jennifer Attonito
Karina Villalba
Jessy G. Dévieux
Publikationsdatum: 21.10.2019
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 5/2020
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02702-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment

Rectal Douching and Microbicide Acceptability among Young Men who Have Sex with Men

Effects of a Combined Exercise Training Program on Health Indicators and Quality of Life of People Living with HIV: A Randomized Clinical Trial

Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine

Gay Men’s Relationship Agreements in the Era of Pre-exposure Prophylaxis: An Analysis of Australian Behavioural Surveillance Data